Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The high prevalence of mutators in this setting strongly contrasts with what has been documented for onset of chronic infections (10%) [83], environment (6%) [84], or acute infections (<1%) [85].”
From Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms (2023) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolution of high mutation rates in experimental populations of E. coli
Sniegowski, P. D., Gerrish, P. J., & Lenski, R. E. (1997) · Nature · doi:10.1038/42701 · Cited by 879
COMPETITION BETWEEN HIGH AND LOW MUTATING STRAINS OF ESCHERICHIA COLI
Chao, L., & Cox, E. C. (1983) · Evolution · doi:10.1111/j.1558-5646.1983.tb05521.x · Cited by 255
Research works printed but not linked: 41
- Anthony, 2002, Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients, J Clin Microbiol, 40, 2772, 10.1128/JCM.40.8.2772-2778.2002 · DOI · Paper page
- Barth, 1996, The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa, J Med Microbiol, 45, 110, 10.1099/00222615-45-2-110 · DOI · Paper page
- Bragonzi, 2005, Non-mucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model, J Infect Dis, 192, 410, 10.1086/431516 · DOI
- Bragonzi, 2006, Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis, Microbiology, 152, 3261, 10.1099/mic.0.29175-0 · DOI
- Burns, 2005, Hypermutability in CF pathogens, Pediatr Pulmonol Suppl, 28, 115
- Campoy, 2000, Virulence and mutation rates of Salmonella typhimurium strains with increased mutagenic strength in a mouse model, FEMS Microbiol Lett, 187, 145, 10.1111/j.1574-6968.2000.tb09151.x · doi:10.1111/j.1574-6968.2000.tb09151.x
- Cash, 1979, A rat model of chronic respiratory infection with Pseudomonas aeruginosa, Am Rev Respir Dis, 119, 453
- Ciofu, 2005, Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation, Antimicrob Agents Chemother, 49, 2276, 10.1128/AAC.49.6.2276-2282.2005 · DOI · Paper page
- 2005, Performance Standards for Antimicrobial Susceptibility Testing. Fifteenth informational supplement, M100-S15
- Deretic, 1995, Pseudomonas aeruginosa , mucoidy and the chronic infection phenotype in cystic fibrosis, Trends Microbiol, 3, 351, 10.1016/S0966-842X(00)88974-X · DOI
- Dinesh, 2003, European-wide distribution of Pseudomonas aeruginosa clone C, Clin Microbiol Infect, 9, 1228, 10.1111/j.1469-0691.2003.00793.x · DOI
- Friedberg, 1995, DNA Repair and Mutagenesis
- Funchain, 2000, The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness, Genetics, 154, 959, 10.1093/genetics/154.3.959 · DOI · Paper page
- Giraud, 2001, Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut, Science, 291, 2606, 10.1126/science.1056421 · DOI · Paper page
- Gutiérrez, 2004, Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients, Antimicrob Agents Chemother, 48, 3573, 10.1128/AAC.48.9.3573-3575.2004 · DOI · Paper page
- Häussler,, 1999, Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis, Clin Infect Dis, 29, 621, 10.1086/598644 · DOI · Paper page
- Hava, 2002, Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors, Mol Microbiol, 45, 1389
- Hogardt, 2006, Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates, Int J Med Microbiol, 296, 313, 10.1016/j.ijmm.2005.12.018 · doi:10.1016/j.ijmm.2005.12.018
- LeClerc, 1996, High mutation frequencies among Escherichia coli and Salmonella pathogens, Science, 274, 1208, 10.1126/science.274.5290.1208 · DOI · Paper page
- Lee, 2006, Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial, Genome Biol, 7, R90, 10.1186/gb-2006-7-10-r90 · DOI · Paper page
- Luzar, 1985, Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition, Infect Immun, 50, 577, 10.1128/IAI.50.2.577-582.1985 · DOI
- Macia, 2005, Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections, Antimicrob Agents Chemother, 49, 3382, 10.1128/AAC.49.8.3382-3386.2005 · DOI · Paper page
- Macia, 2006, Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa, Antimicrob Agents Chemother, 50, 975, 10.1128/AAC.50.3.975-983.2006 · DOI
- Merino, 2002, A hypermutator phenotype attenuates the virulence of Listeria monocytogenes in a mouse model, Mol Microbiol, 44, 877, 10.1046/j.1365-2958.2002.02929.x · doi:10.1046/j.1365-2958.2002.02929.x
- Miller, 1996, Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair, Annu Rev Microbiol, 50, 625, 10.1146/annurev.micro.50.1.625 · DOI · Paper page
- Nilsson, 2004, Experimental adaptation of Salmonella typhimurium to mice, Genetics, 168, 1119, 10.1534/genetics.104.030304 · DOI
- Oliver, 2000, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science, 288, 1251, 10.1126/science.288.5469.1251 · DOI · Paper page
- Oliver, 2002, The mismatch repair system ( mutS , mutL and uvrD genes) in Pseudomonas aeruginosa : molecular characterization of naturally occurring mutants, Mol Microbiol, 43, 1641, 10.1046/j.1365-2958.2002.02855.x · DOI · Paper page
- Oliver, 2004, Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections, Antimicrob Agents Chemother, 48, 4226, 10.1128/AAC.48.11.4226-4233.2004 · DOI
- Potvin, 2003, In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets, Environ Microbiol, 5, 1294, 10.1046/j.1462-2920.2003.00542.x · DOI · Paper page
- Prunier, 2003, High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains, J Infect Dis, 187, 1709, 10.1086/374937 · DOI · Paper page
- Radman, 2000, Evolution-driving genes, Res Microbiol, 151, 91, 10.1016/S0923-2508(00)00122-4 · DOI
- Ratjen, 2003, Cystic fibrosis, Lancet, 361, 681, 10.1016/S0140-6736(03)12567-6 · DOI · Paper page
- Roman, 2004, Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains, J Clin Microbiol, 42, 1450, 10.1128/JCM.42.4.1450-1459.2004 · DOI
- Römling, 1997, Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats, J Mol Biol, 271, 386, 10.1006/jmbi.1997.1186 · DOI
- Stover, 2000, Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen, Nature, 406, 959, 10.1038/35023079 · DOI · Paper page
- Taddei, 1997, Role of mutator alleles in adaptive evolution, Nature, 387, 700, 10.1038/42696 · DOI · Paper page
- Tümmler, 1991, Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients, J Clin Microbiol, 29, 1265, 10.1128/JCM.29.6.1265-1267.1991 · doi:10.1128/jcm.29.6.1265-1267.1991
- Watson, 2004, Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum, Microbiology, 150, 2947, 10.1099/mic.0.27230-0 · DOI
- Worlitzsch, 2002, Effects of reduced mucus oxygen concentration in airway Pseudomonas infection of cystic fibrosis patients, J Clin Invest, 109, 317, 10.1172/JCI0213870 · DOI · Paper page
- Zahrt, 1999, Effect of mutS and recD mutations on Salmonella virulence, Infect Immun, 67, 6168, 10.1128/IAI.67.11.6168-6172.1999 · doi:10.1128/iai.67.11.6168-6172.1999
Cited by
Mena, A., Smith, E. E., Burns, J. L., Speert, D. P., Moskowitz, S. M., Perez, J. L., & Oliver, A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01147-08 · Cited by 251
“aeruginosa is the high prevalence of DNA mismatch repair (MMR) system-deficient hypermutable (or mutator) strains, which are detected in 30 to 60% of the patients, in contrast to acute infections, for which a prevalence of less than 1% has been reported (1, 6, 16, 21, 24, 25).”
BackgroundResultSelf-citationMechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100129 · Cited by 170
Self-citationBaldan, R., Cigana, C., Testa, F., Bianconi, I., De Simone, M., Pellin, D., Di Serio, C., Bragonzi, A., & Cirillo, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089614 · Cited by 163
“3 years and carried several patho-adaptive traits, including mucoid and hypermutable phenotypes (Table 1) as reported previously [23,31].”
Self-citation
Metadata
- Authors
- Montanari, S., Oliver, A., Salerno, P., Mena, A., Bertoni, G., Tümmler, B., Cariani, L., Conese, M., Döring, G., & Bragonzi, A.
- Affiliations
- Institute for Experimental Treatment of Cystic Fibrosis, Scientific Institute H. S. Raffaele, Milano, Italy
- Servicio de Microbiologìa Hospital Son Dureta, Palma de Mallorca, Spain
- Dipartimento di Scienze Biomolecolari e Biotecnologie, Università degli Studi di Milano, Milano, Italy
- Klinische Forschergruppe, OE 6710, Medizinische Hochschule Hannover, Hannover, Germany
- Ospedale Maggiore Policlinico, CF Clinic, Milano, Italy
- Institute of Medical Microbiology and Hygiene, Universitätsklinikum Tübingen, Tübingen, Germany
- Venue
- Microbiology
- Publisher
- Microbiology Society
- Published
- 2007-05-01
- Volume
- 153
- Issue
- 5
- Pages
- 1445-1454
- ISSN
- 1350-0872
- 1465-2080
- Cited by
- 87
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.